Asian drug market stocks slides: Trump’s 100% pharmaceutical tariffs shake market; broader impact on Japan likely minimal

Asian drug stocks faced a downturn. This followed US President Trump’s tariff threat on imported pharmaceuticals. South Korean and Japanese drugmakers experienced declines. Samsung Biologics and Sumitomo Pharma saw significant drops. Celltrion bucked the trend with a slight gain. Experts suggest limited broader economic impact. The US government’s tariff rate is expected to rise.

Read More

Step up lending for public infra, MSMEs: FM Sitharaman to banks

Finance Minister Nirmala Sitharaman urged banks with strong balance sheets to increase lending for public infrastructure, industry, and MSMEs, emphasizing their crucial role amid global uncertainty. She highlighted India’s resilience due to strong economic fundamentals and urged public sector banks to maintain professional management and customer-centric approaches. The government is emphasizing increased capital for MSMEs…

Read More

Tired of OTPs? RBI is open to options

RBI’s Authentication Directions, 2025, signals the phasing out of OTP-only second-factor authentication for payments, prioritizing enhanced security and user choice. The new framework encourages biometrics, app-based tokens, and device-native methods, shifting liability to issuers. Banks and payment providers must adopt alternative 2FAs by April 2026 for domestic transactions and October 2026 for cross-border payments.

Read More